Abstract
Background: The role of conservative surgery and radiation therapy (CS and RT) in the treatment of patients with infiltrating ductal carcinoma is well established. However, the efficacy of CS and RT for patients with infiltrating lobular carcinoma is less well documented. The goal of this study was to examine treatment outcome after CS and RT for patients with infiltrating lobular carcinoma and to compare the results to those of patients with infiltrating ductal carcinoma and patients with mixed ductal–lobular histology.
Methods: Between 1970 and 1986, 1624 patients with Stage I or II invasive breast cancer were treated with CS and RT consisting of a complete gross excision of the tumor and ≥6000 cGy to the primary site. Slides were available for review for 1337 of these patients (82%). Of these, 93 had infiltrating lobular carcinoma, 1089 had infiltrating ductal carcinoma, and 59 had tumors with mixed ductal and lobular feature these patients constitute the study population. The median follow-up time for surviving patients was 133 months. A comprehensive list of clinical and pathologic features was evaluated for all patients. Additional histologic features assessed for patients with infiltrating lobular carcinoma included histologic subtype, multifocal invasion, stromal desmoplasia, and the presence of signet ring cells.
Results: Five and 10-year crude results by site of first failure were similar for patients with infiltrating lobular, infiltrating ductal, and mixed histology. In particular, the 10-year crude local recurrence rates were 15%, 13%, and l3% for patients with infiltrating lobular, infiltrating ductal, and mixed histology, respectively. Ten-year distant/regional recurrence rates were 22%, 23%, and 20% for the three groups, respectively. In addition, the 10-year crude contralateral breast cancer rates were 4%, 13% and 6% for patients with infiltrating lobular, infiltrating ductal and mixed histology, respectively. In a multiple regression analysis which included established prognostic factors, histologic type was not significantly associated with either survival or time to recurrence.
Conclusions: Patients with infiltrating lobular carcinoma have a similar outcome following CS and RT to patients with infiltrating ductal carcinoma and to patients with tumors that have mixed ductal and lobular features. We conclude that the presence of infiltrating lobular histology should not influence decisions regarding local therapy in patients with Stage I and II breast cancer.
Similar content being viewed by others
References
Ashikari R, Huvos A, Urban J, Robbins GF: Infiltrating lobular carcinoma of the breast. Cancer 31: 110-116, 1973
Fisher ER, Gregorio RM, Redmond C, Vellios F, Sommers SC, Fisher B: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). I. Observations concerning the multicentricity of mammary cancers. Cancer 35: 247-254, 1975
Lesser M, Rosen PP, Kinne D: Multicentricity and bilaterality in invasive breast carcinoma. Surgery 91: 234-240, 1982
Tinnemans JGM, Wobbes T, van der Sluis RF, Lubbers E-JC, de Boer HHM: Multicentricity in nonpalpable breast carcinoma and its implications for treatment. Am J Surg 151: 334-338, 1986
Gump FE, Shikora S, Habif DV, Kister S, Logerfo P, Estabrook A: The extent and distribution of cancer in breasts with palpable primary tumors. Ann Surg 204: 384-390, 1986
Kurtz IM, Jacquemier J, Torhorst J, Spitalier J-M, Amalric R, Hunig R et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63: 1630-1635, 1989
Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR: Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 64: 448-454, 1989
Poen JC, Tran L, Juillard G, Selch MT, Giuliano A, Silverstein M et al.: Conservation therapy for invasive lobular carcinoma of the breast. Cancer 69: 2789-2795, 1992
Weiss M, Fowble B, Solin LF, Yeh I-T, Schultz DJ: Outcome of conservative therapy for invasive breast cancer by histologic subtype. In J Radiat Oncol Biol Phys 23: 941-947, 1992
White JR, Gustafson GS, Wimbish K, Ingold JA, Lucas RJ, Levine AJ et al.: Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. Cancer 74: 640-647, 1994
Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T et al.: Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 77: 113-120, 1996
Fisher ER, Sass R, Fisher B, Gregono R, Brown R, Wickerham L: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 57: 1717-1724, 1986
Silverstein MJ, Lewinsky BS, Walsman JR, Gierson ED, Colburn WJ, Senofsky GM et al.: Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73: 1673-1677, 1994
Haffty BG, Perrotta PL, Ward B, Moran M, Beinfield M, McKhann C, et al.: Conservatively treated breast cancer: Outcome by histologic subtype. The Breast J 3: 7-14, 1997
Salvadori B, Bignazoli E, Veronesi P, Saccozzi R, Rilke F: Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg I 84: 106-109, 1997
Bouvet M, Ollila DW, Hunt KK, Babiera GV, Spitz FR, Giuliano AE et al.: Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol 4: 650-654, 1997
Mate TP, Carter D, Fischer DB, Hartman PV, McKhann C, Merino M et al.: A clinical and histopathologic analysis of conservative surgery and radiation therapy in Stage I and II breast carcinoma. Cancer 58: 1995-2002, 1986
Fechner RE: Histologic variants of infiltrating lobular carcinoma of the breast. Hum Pathol 29: 1539-1545, 1975
Fisher ER, Gregorio RM, Redmond C, Fisher B: Tubulolobular invasive breast cancer: A variant of invasive lobular cancer. Hum Pathol 8: 679-683, 1977
Martinez V, Azzopardi JG: Invasive lobular carcinoma of the breast: Incidence and variants. Histopathol 3: 467-488, 1979
van Bogaert L, Maldague P: Infiltrating lobular carcinoma of the female breast. Deviations from the usual histopathologic appearance. Cancer 45: 979-984, 1980
Dixon JM, Anderson TJ, Page DL, Lee DL, Duffly SW: Infiltrating lobular carcinoma of the breast. Histopathol 6: 149-161, 1982
DiConstanzo D, Rosen PP, Gareen I, Franklin S, Lesser M: Prognosis in infiltrating lobular carcinoma. An analysis of 'classical' and 'variant' tumors. Am J Surg Pathol 14: 12-23, 1990
Horn PL, Thomson WD: Risk of contralateral breast cancer: Association with histologic, clinical, and therapeutic factors. Cancer 62: 412-424, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peiro, G., Bornstein, B.A., Connolly, J.L. et al. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59, 49–54 (2000). https://doi.org/10.1023/A:1006384407690
Issue Date:
DOI: https://doi.org/10.1023/A:1006384407690